Key result
PCSK9 vaccines show therapeutic promise but remain unproven in clinical practice.
Exploring PCSK9 vaccine potential and AI integration in cardiology, suggesting critical advancements.
The Miriam Hospital and its parent organization, Lifespan, with a continued interest in the transition to digital working and use of artificial intelligence in cardiology.
No takes yet. Share an insight, caveat, or question.
Sahebkar et al. (2021) studied this question. A PCSK9 vaccine remains a promising but not yet clinically realized therapeutic strategy.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: